You can buy or sell GTHX and other stocks, options, and ETFs commission-free!
G1 Therapeutics, Inc. engages in the development of small molecule therapeutics for the treatment of patients with cancer. Its products pipeline includes trilaciclib, rintodestrant, and lerociclib. The company was founded by Kwok-Kin Wong and Norman E. Sharpless on May 19, 2008 and is headquartered in Research Triangle Park, NC. The listed name for GTHX is G1 Therapeutics, Inc. Common Stock.
Research Triangle Park, North Carolina
52 Week High
52 Week Low
-$0.87 per share
-$0.67 per share